Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to compare patient-centered outcomes when screening digital breast tomosynthesis (DBT) exams are interpreted with versus without a leading FDA-cleared artificial int...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
NCT07075679 · Breast Cancer Screening, Artificial Intelligence (AI), and more
NCT07236840 · CNS Tumor, Artificial Intelligence (AI), and more
NCT07079592 · Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis, and more
NCT07265427 · Digital Health, Artificial Intelligence (AI)
NCT06957093 · Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)
University of California Los Angeles Health System
Los Angeles, California
University of California, San Diego
San Diego, California
University of Miami Health System
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions